Malkiel et al. showed an impairment of anergy induction in ANA+ naïve B cells in SLE patients, assessed by the percentage of IgMlow ANA+ naïve B cells, and restoration with belimumab treatment [66]. This evidence concerns the gene BTG3 and systemic lupus erythematosus.